Reactivity: Human (Tested in Development)
Application: Single Cell 3' Sequencing (Qualified)
Regulatory Status: RUO
Description: Description The BD ® OMICS-One Comprehensive Immuno-Oncology Protein Panel consists of 10 single tubes, 2 tubes of T-Cell Protein Panel (1 test/tube) containing 30 different specificities against major T-cell markers, 2 tubes of B-Cell Protein Panel (1 test/tube) containing 30 different specificities against major B-cell markers, 2 tubes of Tumor Protein Panel (1 test/tube) containing 30 different specificities against major tumor markers, 2 tubes of NK-Cell Protein Panel (1 test/tube) containing 30 different specificities against major NK-cell markers and 2 tubes of APC/Myeloid-Cell Protein Panel (1 test/tube) containing 30 different specificities against major APC/myeloid-cell markers. Designed and optimized to work on the BD Rhapsody™ System, the Comprehensive Immuno-Oncology Protein Panel is tested to work seamlessly alongside the BD Rhapsody™ Whole Transcriptome Analysis (WTA) Assay, Targeted mRNA Assay, BD ® Single-Cell Multiplexing Kit (SMK), BD ® Intracellular CITE-seq (IC-AbSeq) Assay, and BD Rhapsody™ TCR/BCR Next Multiomic Assay for human. The individual antibodies were each conjugated to an oligonucleotide that contains a specific antibody barcode sequence flanked by a polyA tail on the 3' end and a common PCR handle (PCR primer binding site) on the 5' end. All AbSeq barcode sequences were generated in-silico with minimal sequence similarity to the human genomes, have low predicted secondary structure, and have high Hamming distance within the BD antibody-oligo portfolio, to allow for sequencing error correction and unique mapping. The polyA tail of the oligonucleotide allows the barcode sequence to be captured by BD Rhapsody™ Enhanced Cell Capture Beads. The 5' PCR handle allows for efficient library generation for various sequencing platforms. Each individual antibody exists at an optimal concentration within the 129-plex panel to enable superior target and population resolution. The Comprehensive Immuno-Oncology Protein Panel is designed with SMART technology. SMART technology helps lower sequencing cost while increasing data resolution by attenuating antibodies that target high-expressing primary markers and allowing reallocation of sequencing reads to markers expressed at lower levels. With SMART technology, markers low in expression can be quantified without having to do deeper sequencing and incurring high sequencing cost. There are eight specificities attenuated in the Comprehensive Immuno-Oncology Protein Panel, CD2, CD4, , CD31, CD43, CD44, CD45, HLA-DR, and HLA-ABC.
Preparation And Storage: Store at 2-8°C and protected from prolonged exposure to light. Do not freeze.
Recommended Assay Procedures: This reagent is provided lyophilized in a pre-titrated format. Each test can stain up to 2 million cells. 1. Remove one tube of BD ® OMICS-One T-Cell Protein Panel, one tube of BD ® OMICS-One B-Cell Protein Panel, one tube of BD ® OMICS-One Tumor Protein Panel, one tube of BD ® OMICS-One NK-Cell Protein Panel and one tube of BD ® OMICS-One APC/Myeloid-Cell Protein Panel from foil bags and bring up to room temperature for 5 minutes. 2. Make sure all pellets are located at the bottom of the tubes. If not, briefly centrifuge to collect the contents at the tube bottom. 3. For each tube, add 35 µL of nuclease-free water to the bottom of the tube and allow antibodies to reconstitute for 5 minutes at room temperature. 4. Place the reconstituted antibodies on ice until the cells are ready for staining. Note: Reconstitute antibody immediately before cell staining. Prolonged incubation of reconstituted antibodies may increase the non-specific background. Note: For options for BD ® AbSeq Antibody-Oligo drop-in, reach out to technical support for calculation. 5. Prepare the staining solution with cells using the table below for substeps a–e. _______________________________________________________________________________________________________ Component Co-labeling with Sample Tags Sequential labeling with Sample Tags or no Sample Tags Fc Block (µL) No Fc Block (µL) Fc Block (µL) No Fc Block (µL)______ 5‑panel pool (35 µL × 5) 175 175 175 175 SMK 20 20 0 0 Cell suspension in Fc Block 25 0 25 0 Cell suspension in FBS 0 25 0 25 Total staining volume 220 220 200 200___________________ Prepare the 5-panel pool by combining the five tubes of 35‑µL rehydrated solutions from step 4. a. For co-labeling with Sample Tags, for each sample, add 20 μL Sample Tag to the 5-panel pool. b. Pipet-mix the mixture, briefly centrifuge to collect the contents at the tube bottom, and place back on ice. c. Centrifuge cells at 400 × g for 5 minutes. If Fc Block is used, proceed to substep d. If Fc Block is not used, skip to substep e. d. (Optional) For samples containing myeloid and B lymphocytes, BD Biosciences recommends blocking nonspecific Fc Receptor–mediated false-positive signals with Human BD Fc Block (catalog number 564220). i. To perform blocking, pipet the Fc Block MasterMix into a new 1.5-mL LoBind tube on ice: _________________________________________________________________________________ Component 1 sample (µL)* 1 sample + 20% overage (µL) FBS† (catalog number 554656) 20.0 24.0 Fc Block‡ (catalog number 564220) 5.0 6.0 Total 25.0 30.0 * Sufficient for up to 1 million cells. To block more cells, adjust the volume. † FBS = BD Pharmingen™ Stain Buffer. ‡ Fc Block = BD Pharmingen™ Human BD Fc Block. ii. Pipet-mix the Fc Block MasterMix and briefly centrifuge. Place on ice. iii. Remove the supernatant from the cells without disturbing the pellet. iv. Resuspend the cells in 25 μL of Fc Block MasterMix. v. Incubate the cells at room temperature (15°C to 25°C) for 10 minutes. vi. Add the mixture from substep c to the cell suspension. Pipet-mix and proceed to step 6. e. Remove the supernatant from the cells without disturbing the pellet. Add 25 μL Stain Buffer (FBS) to resuspend the cell pellet. Pipet-mix. 6. Transfer the cells with BD ® AbSeq labeling MasterMix into a new 5-mL polystyrene Falcon tube. 7. Stain the cells on ice for 30 minutes. 8. Add 3–4 mL Stain Buffer (FBS) to labelled cells and pipet-mix. 9. Centrifuge at 400 × g for 5 minutes. 10. Uncap the tube and invert to decant supernatant into biohazardous waste. Keep the tube inverted and gently blot on a lint-free wiper to remove residual supernatant from tube rim. 11. Repeat steps 8 – 10 twice more for a total of three washes. 12. Resuspend the final washed cell pellet in 620 µL cold Sample Buffer from the BD Rhapsody™ Enhanced Cartridge Reagent V3 (catalog number 667052) and proceed to single cell capture with on-cartridge washing described in substeps a–c. Refer to the BD Rhapsody™ HT Single-Cell Analysis System Single-Cell Capture and cDNA Synthesis Protocol (Doc ID 23-24252) or BD Rhapsody™ HT Xpress System Single-Cell Capture and cDNA Synthesis Protocol (Doc ID 23-24253) for additional details. Note: Perform on-cartridge washing after cell settling (8-minute incubation) as described in the following substeps. a. At the protocol section of "Loading cells in BD Rhapsody™ 8-Lane Cartridge", after cell load, incubate the cartridge in the dark at room temperature for 8 minutes. b. P lace the cartridge on the BD Rhapsody™ HT Xpress and perform the On-Cartridge Wash steps as follows: _____________________________________________________________ Material to load Volume (µL) 1 lane Pipette Mode Air 380 Prime/Wash Cold Sample Buffer 380 Prime/Wash Air 380 Prime/Wash Cold Sample Buffer 380 Prime/Wash c. (Optional) Perform the scanner step: Cell Load Scan, if using BD Rhapsody™ HT Single-Cell Analysis System Single-Cell Capture and cDNA Synthesis Protocol (Doc ID 23-24252). No need for 8-minute delay before scanning. Warning: All biological specimens and materials are considered biohazardous. Handle as if capable of transmitting infection and dispose using proper precautions in accordance with federal, state, and local regulations. Never pipette by mouth. Wear suitable protective clothing, eyewear, and gloves. List of all 30 Human AbSeq specificities included in the BD® OMICS-One T-Cell Protein Panel: _____________________________________________________________________________ Specificity Clone Oligo ID BD® AbSeq Barcode Sequence ___________ CD103** Ber-ACT8 AHS0001 AAATAGTATCGAGCGTAGTTAAGTTGCGTAGCCGTT CD137 4B4-1 AHS0003 TGACAAGCAACGAGCGATACGAAAGGCGAAATTAGT CD45RA HI100 AHS0009 AAGCGATTGCGAAGGGTTAGTCAGTACGTTATGTTG CD69 FN50 AHS0010 CAATAACGGGTCATAGTAAGTCGCGAGTAAGAGGGC CD278 DX29 AHS0012 ATAGTCCGCCGTAATCGTTGTGTCGCTGAAAGGGTT CD134 (OX40) ACT35 AHS0013 GGTGTTGGTAAGACGGACGGAGTAGATATTCGAGGT CD279 (PD-1)† EH12.1 AHS0014 ATGGTAGTATCACGACGTAGTAGGGTAATTGGCAGT CD366 (TIM-3) 7D3 AHS0016 TAGGTAGTAGTCCCGTATATCCGATCCGTGTTGTTT CD223 (Lag3) T47-530 AHS0018 CGGCATGAATTAGGCGAGACTTAGTATACGAGCTGG CD95 (Fas)* DX2 AHS0023 GGCCCGTTAGAGTTGGTATCCGTATGAAGGTTAGCT CD25 2A3 AHS0026 AGTTGTATGGGTTAGCCGAGAGTAGTGCGTATGATT CD127 HIL-7R-M21 AHS0028 AGTTATTAGGCTCGTAGGTATGTTTAGGTTATCGCG CD183 1C6/CXCR3 AHS0031 AAAGTGTTGGCGTTATGTGTTCGTTAGCGGTGTGGG CD4 SK3 AHS0032 TCGGTGTTATGAGTAGGTCGTCGTGCGGTTTGATGT CD196 (CCR6) 11A9 AHS0034 ACGTGTTATGGTGTTGTTCGAATTGTGGTAGTCAGT CD45RO UCHL1 AHS0036 TGAGAGGTTATTGGGCGTATGACTTCGGTGATTGTG CD194 (CCR4) 1G1 AHS0038 AATATTAGTGGGTCCTCGCGTTGGCCGGTTGTTAGT CD62L DREG-56 AHS0049 ATGGTAAATATGGGCGAATGCGGGTTGTGCTAAAGT CD272 J168-540 AHS0052 GTAGGTTGATAGTCGGCGATAGTGCGGTTGAAAGCT CD154 TRAP1 AHS0077 TAAGAGGTAAGTGCATTCGGGTATAGGCGTGATTTG CD357 (GITR) V27-580 AHS0104 TCTGTGTGTCGGGTTGAATCGTAGTGAGTTAGCGTG CD28 L293 AHS0138 TTGTTGAGGATACGATGAAGCGGTTTAAGGGTGTGG TCRgd 11F2 AHS0142 CTCGTGGGTTAGGCTTGATCGTAGTTATGTATGGTT CD44† L178 AHS0167 GTGATTGATTAGGACAGTTCGTTGCTTAGTAGTGGG TCR Va24-Ja18 6B11 AHS0175 TTCTGGTTCGGTTGAGCTACTAATTTCGTTGGATGG CD161 (KLRB1)‡ HP-3G10 AHS0205 TTTAGGACGATTAGTTGTGCGGCATAGGAGGTGTTC CD8 SK1 AHS0228 AGGACATAGAGTAGGACGAGGTAGGCTTAAATTGCT CD3‡ UCHT1 AHS0231 AGCTAGGTGTTATCGGCAAGTTGTACGGTGAAGTCG CD197 (CCR7) 2-L1-A AHS0273 AATGTGTGATCGGCAAAGGGTTCTCGGGTTAATATG TIGIT tgMab-2 AHS0411 AGAGGGTTTAGTCAAGGTCGTGCGTATAGTTCAGGT List of all 30 Human AbSeq specificities included in the BD® OMICS-One B-Cell Panel: _____________________________________________________________________________ Specificity Clone Oligo ID BD® AbSeq Barcode Sequence___________ CD20 2H7 AHS0008 TTGCTTGTTGCGCGTTAGAGAGTATGTCGGGAGATG CD275 2D3/B7-H2 AHS0011 GTTTATATGTACGACGCCCGGTTGACGAGTGGAAGT CD38‡‡ HIT2 AHS0022 GTCAACGATGGGTAGCGGTAGAAATAACGGAACTGG CD95(Fas)* DX2 AHS0023 GGCCCGTTAGAGTTGGTATCCGTATGAAGGTTAGCT CD27‡‡ M-T271 AHS0025 TGTCCGGTTTAGCGAATTGGGTTGAGTCACGTAGGT CD19 SJ25C1 AHS0030 TAGTAATGTGTTCGTAGCCGGTAATAATCTTCGTGG HLA-DR*** G46-6 AHS0035 TGTTGGTTATTCGTTAGTGCATCCGTTTGGGCGTGG CD185 (CXCR5) RF8B2 AHS0039 AGGAAGGTCGATTGTATAACGCGGCATTGTAACGGC CD24†† ML5 AHS0042 ACTTTGGGTTGAGCGCATGATTATTCGTGACACTTT CD80*** L307.4 AHS0046 GAGGGTAACGGGTGTCCAAATATCGGCTGTGTAAGT CD5 UCHT2 AHS0047 ACGAAGCGAGCGAAGAACCTATGCGATTGAGTAAGT CD10 HI10a AHS0051 CCTGTTTGATGCGTACGGAGATTTAGCGGATTTATG IgD IA6-2 AHS0058 TGAGGGATGTATAGCGAGAATTGCGACCGTAGACTT IgG G18-145 AHS0059 AGGTAGGTTATCGTAGGGTAGACTTAGCGGGCATTG CD184 (CXCR4)‡‡ 12G5 AHS0060 CAGTGTTTAGAGCGGGTTGCATATGTCGTTTAGAGG CD34†† 581 AHS0061 TGGGTGTATTACGGTTAGTTTATGCGCGAAGGTGTT CD21 B-ly4 AHS0074 GTATTCGCGTATTGTCAGTCGGTAGGGTTATGGTCT CD9 M-L13 AHS0082 GGGTTGTAAGTCGTCGGAAGTGTGAAGCGTATAGTG CD126 M5 AHS0096 AATGGTGAATCGCCCTAGCAAGTGGTATCGGAATCG CD30 BERH8 AHS0114 CCAGTGTAGATTGAGCCGTCGATTTAGTTAGCAGTG CD40*** 5C3 AHS0117 GGTGTAATTGGGCTAGAACGTATATGCGGTAAGGCG CD138 MI15 AHS0121 TAAGCTGCCGGTATTGGAAACGTATCGATCTATTGG CD79B CB3-1 AHS0153 CATCATGAGTAGTTGCTTCGGCGAGTAGGTTTAATT CD22 HIB22 AHS0195 TGGTTCGTGACTGTATAGGCTTAGCTTAGGCAATTT IgM G20-127 AHS0198 TTTGGAGGGTAGCTAGTTGCAGTTCGTGGTCGTTTC CD43 1G10 AHS0200 ATGGCGGATGGATTTGTCGGTGATATTGCTCTCGTT CD268 (BAFF-R) 11C1 AHS0206 TGTGAATGAGTTAAGCGTCGCGGATATGTAGAGCCT CD23 EBVCS-5 AHS0210 TTTGATGTGGGCGGGTTGTATTACGGTTTCGAGTCT CD73 AD2 AHS0216 AAAGTAGGGTCGATCAAGGGAGTTAACGGTAGCGCT CD1d CD1d42 AHS0219 GTTAGGATTATTGACGTACCGAGTTAGGAGTGATTG List of all 30 Human AbSeq specificities included in the BD® OMICS-One Tumor Protein Panel: ______________________________________________________________________________ Specificity Clone Oligo ID BD® AbSeq Barcode Sequence___________ CD274 (PD-L1)‡‡‡ MIH1 AHS0004 ATCGTAAGGCTCGTGGTTCGTAAGTAAGTTCGTATC CD279 (PD-1)† EH12.1 AHS0014 ATGGTAGTATCACGACGTAGTAGGGTAATTGGCAGT CD45‡‡‡ HI30 AHS0040 GTGCGAAATGGCGGAATGTTATCTGCGAATGTAGTC CD324 (E-cad) 67A4 AHS0041 GATATGAATGGGTTGCGGTGTAAAGTCGTAATGGTT CD24†† ML5 AHS0042 ACTTTGGGTTGAGCGCATGATTATTCGTGACACTTT CD90 5E10 AHS0045 GACTATATGTACGGTGTTAATTCGGGATCCTGCGCT CD34†† 581 AHS0061 TGGGTGTATTACGGTTAGTTTATGCGCGAAGGTGTT CD117 YB5.B8 AHS0064 GGATTAGTTGTCGTTATAGGGAGTGCGTTCTTAGCG HLA-A,B,C G46-2.6 AHS0066 GATATGCATGGCGAGTAGGTAGAACGAAGCTTAGGT CD54††† HA58 AHS0076 AAGAGAATATATGCGTGCGTTGTTAAGGGAATGCGT CD29 MAR4 AHS0080 TGGTAAGGTGGTTGCGAGTAAGTAGCGGTGAGTTGT CD47 B6H12 AHS0087 TGTTAGGTTCGACGTATTATGTGTAGATCCGCAAGG CD326 (EpCam) EBA-1 AHS0089 TTGAGCGTAAAGTTGCGTCCGGTAATTGAGTTGCGT CD66 B1.1/CD66 AHS0094 GTCTGCGCAAGGTAAGCTAAGTAACGAAAGGGATCT CD133 W6B3C1 AHS0103 TTTGGTATTGGCACGGTTTGTAGCGAGTTGACGGTC CD26 M-A261 AHS0109 TGTAGGTTGCGCGGTTATTAGGGTATTATCGATCTG CD155 TX24 AHS0111 GCGGTGGATCGATGGGTATAGTTGGTAATTTGCGTC CD146 P1H12 AHS0127 AGGTTATTTAGGTGACGGTTGTATTGACGAGAGAGG C-MET 3D6 AHS0132 AGCGTGAGTTGTCGGTAGTTAATTATCGGAGAGTTT ITGRN BTA 7 FIB504 AHS0158 TTTCAGTTTGGTCGCAGTTAAGGTATCGTATGGGTC CD44 L178 AHS0167 GTGATTGATTAGGACAGTTCGTTGCTTAGTAGTGGG CD31 (PECAM1)††† WM59 AHS0170 CTAAGGGACGTAATTGAGTTTCGGTGATCGCAGTTT EphB2 2H9 AHS0176 TATTGCGGGTAGGATTTGTCTCGAAGCGTAGGTAGC Vista‡‡‡ MIH65.RMAB AHS0187 ATCAGGGAATCTCGGTAAGTTAAACGTGTATAGTGC PDPLN LPMAB-17 AHS0192 TTTATGAGTATTACGTCTGTTGCGATTGTTGGCGGT NOTCH1 MHN1-519 AHS0214 CGTAGTAGGAGCGTGTTTCATCGGCATTATCGTTTG CD325 (n-Cad) 8C11 AHS0223 TAGGATGAGTTTCGTAAGTAAGGTAGTCGTATGGCT CD58 1C3 AHS0237 TTGGTGAGTATTGGTGCGTAGTATGCGGGATGTTTG EGFR EGFR.1 AHS0241 ATATGATTGATGCGGGTTAGCCTACAGATTCGAGTT CD227 (MUC1) HMFG2 AHS0247 AGTGCATGGTTAGTAGGTGTGAGTCGTTAGATATTC List of all 30 Human AbSeq specificities included in the BD ® OMICS-One NK-Cell panel: ______________________________________________________________________________ Specificity Clone Oligo ID BD® AbSeq Barcode Sequence___________ CD11b**** M1/70 AHS0005 ATCGTTATTCGTTGTAGTTCGCCCGGTTTGAGTAGT CD56 NCAM16.2 AHS0019 AGAGGTTGAGTCGTAATAATAATCGGAAGGCGTTGG CD38‡‡ HIT2 AHS0022 GTCAACGATGGGTAGCGGTAGAAATAACGGAACTGG CD27‡‡ M-271 AHS0025 TGTCCGGTTTAGCGAATTGGGTTGAGTCACGTAGGT CD2 RPA-2.10 AHS0029 AAACGTAGATTAGAGCCGGGTATGTCGCAACTGATT CD16**** 3G8 AHS0053 TAAATCTAATCGCGGTAACATAACGGTGGGTAAGGT CD184 (CXCR4)‡‡ 12G5 AHS0060 CAGTGTTTAGAGCGGGTTGCATATGTCGTTTAGAGG CD49d 9F10 AHS0063 TAGGGTGACTTAGCGATTGATGCGTATGTTTGGGCG CD314 (NKG2D) 1D11 AHS0065 TTGAAATGCGATGAGACGTAGAGCGATGTAGGTAGC CD335 (NKP46) 9E2/NKP46 AHS0068 CAATTTGTTCGCGTTTAGTAGTCGTCGTCTTATGGG CD54††† HA58 AHS0076 AAGAGAATATATGCGTGCGTTGTTAAGGGAATGCGT CD226 DX11 AHS0079 GAGTTTATGATTCGTTTCTTCGGTAGTTCGTCGCTT CD94 HP-3D9 AHS0085 GAGGTTAGGATAGGTGTACGGGTCGAGTTGAATTCT CD336 (NKP44) p44-8 AHS0090 AATGCAAACGATATCACGAAGGGTAGTACACGACGG CD49a SR84 AHS0101 ATGACACGAATGCGACGAGAGGCGAAATAGGTTGGT CX3CR1 2A9-1 AHS0125 GGGTTCACGAGGTTTAAAGCGGTAGTATAGGATGCC CD122 Mik-β3 AHS0146 TTAAAGAGATTCGTGGGTATTGGCGCAGTCATTCCT CD140b (PDGFR) 28D4 AHS0151 GACAACATTTAGGACGTGACGAGAGAGTATAGCTTC CD248 B1/35 AHS0156 ATCACTTATTTCGTTTGGAGGGTTCGTAGGCGTTGC CD63 H5C6 AHS0157 TGCAGCGTTAGGACCAAGCGTTTACCGTAGAATATT CD140a α-R1 AHS0160 TTACTGACTTTCGGACGTTGGTTACTTAGGGTTATG CD31 (PECAM1)††† WM59 AHS0170 CTAAGGGACGTAATTGAGTTTCGGTGATCGCAGTTT CD96 6F9 AHS0194 CTAATGTAAGAGCGGACGTTTGGGCACTATATGTTT CD161 (KLRB1)‡ HP-3G10 AHS0205 TTTAGGACGATTAGTTGTGCGGCATAGGAGGTGTTC CD158b (KIR) DX27 AHS0209 CGTAGGAGGATTTCGTCGATGGGTTTGTTAGCGTTC CD158e1 DX9 AHS0211 AGGTTCATTGCGGCATTAGGCGTCATATAGTAGGTG CD337/NKp30 P30-15 AHS0213 GGTAACTGACATGACGGAGCGATAATTTCTGGCGGT CD3‡ UCHT1 AHS0231 AGCTAGGTGTTATCGGCAAGTTGTACGGTGAAGTCG CD329 (Siglec-9) E10-286 AHS0239 CGGGCGCGAAGATAGGATAATAGGTAACGTCAAATG CD106 51-10C9 AHS0251 TCTGATTTAGCGGGTGGACGTATTATAGTGATTGGC_ List of all 30 Human AbSeq specificities included in the BD® OMICS-One APC/Myeloid-Cell panel: ______________________________________________________________________________ Specificity Clone Oligo ID BD® AbSeq Barcode Sequence___________ CD103** BER-ACT8 AHS0001 AAATAGTATCGAGCGTAGTTAAGTTGCGTAGCCGTT CD274 (PD-L1)‡‡‡ MIH1 AHS0004 ATCGTAAGGCTCGTGGTTCGTAAGTAAGTTCGTATC CD11b**** M1/70 AHS0005 ATCGTTATTCGTTGTAGTTCGCCCGGTTTGAGTAGT CD123 7G3 AHS0020 ACAGTTTAGTAGGACGTGAGGTATCGCGAGAATGCC HLA-DR*** G46-6 AHS0035 TGTTGGTTATTCGTTAGTGCATCCGTTTGGGCGTGG CD14 MPHIP9 AHS0037 TGGCCCGTGGTAGCGCAATGTGAGATCGTAATAAGT CD45‡‡‡ HI30 AHS0040 GTGCGAAATGGCGGAATGTTATCTGCGAATGTAGTC CD33 WM53 AHS0044 GTGTTAGTGATTTGATAGGACGCGTTACGAGAGATT CD80*** L307.4 AHS0046 GAGGGTAACGGGTGTCCAAATATCGGCTGTGTAAGT CD16**** 3G8 AHS0053 TAAATCTAATCGCGGTAACATAACGGTGGGTAAGGT CD64 10.1 AHS0055 TTGTGCGGCGTAGTATGGTTATCTCGAGTGAAAGTC CD11c B-LY6 AHS0056 ATGCGTTGCGAGAGATATGCGTAGGTTGCTGATTGG CD163 GHI/61 AHS0062 TATTATGTGCGAACTATGGTATCCGTATTGAGGGCT CD195 (CCR5) 2D7/CCR5 AHS0070 ATGGTTTAGTCGTACGTGGGTTTAGATTGGCGGTGC CD206 19.2 AHS0072 GCTGGTTATCGTTTGAGAGTCGGTATGGAATGCGGT CD32 FLI8.26 AHS0073 GGTTGTAGGTGCGGAATATAAGCGTCGTTGAGGTGT CD273 MIH18 AHS0075 TGAGTAACCGTATGTAATCCGTAATCGTAGAAGCGC CD141 1A4 AHS0083 TGGAAGTAAGTATGGGTCGGCGTAAATTGTGCGTGT CD1c F10/21A3 AHS0088 ATAGATTACATTCGTTTAGCGTTGGGTTCGGTCCGT CD40*** 5C3 AHS0117 GGTGTAATTGGGCTAGAACGTATATGCGGTAAGGCG FCeR1a AER-37 AHS0129 GATATGGCGTGATGGTAGGTTCGGTTTAAGTTAGCG CD169 7-239 AHS0133 CATTAAGCACGAAGGGTATAGGTAGGAACGGTTGGC CD36 IVC7 AHS0135 AATTGTAGTAGTCCGGTGTATGTAGAGTAGGCGTTT CD115 (CSF1R) 9-4D2-1E4 AHS0136 CTGGTGGCGGCGAATTTGGTTACGACATATAGGGTT CD162 KPL-1 AHS0139 CCAGATAGGCGATAGTGTTTAGGAGCGATTAGTGTG CD85K ZM3.8 AHS0179 AGTAGTCGTAGTTGGCGTGAATTGGGCTTATATCTG VISTA‡‡‡ MIH65.RMAB AHS0187 ATCAGGGAATCTCGGTAAGTTAAACGTGTATAGTGC CD15 W6D3 AHS0196 ATAGGCATGGACGACGTAGATAATAAGTGGCGGGTT CD192 (CCR2) LS132.1D9 AHS0208 CATGAGTGAGGCGATATAGTGAGCGGTTTGTAGATT CD116 Hgmcsfr1-M1 AHS0238 CTTAGTTGTAGGATCGAGAGTAGGTGTGCATTGCGT_ * T-Cell and B-Cell Protein Panels contain the same CD95 antibody. † T-Cell and Tumor-Cell Protein Panels contain the same CD279 (PD-1) and CD44 antibody. ‡ T-Cell and NK-Cell Protein Panels contain the same CD161 (KLRB1), and CD3 antibody. ** T-Cell and APC/Myeloid -Cell Protein Panels contain the same CD103 antibody. †† B-Cell and Tumor-Cell Protein Panels contain the same CD24 and CD34 antibody. ‡‡ B-Cell and NK-Cell Protein Panels contain the same CD27, CD38, and CD184 (CXCR4) antibody. *** B-Cell and APC/Myeloid -Cell Protein Panels contain the same HLA-DR, CD40, and CD80 antibody. ††† Tumor and NK-Cell Protein Panels contain the same CD54 and CD31 (PECAM1) antibody. ‡‡‡ Tumor and APC/Myeloid-Cell Protein Panels contain the same CD274 (PD-L1), CD45, and VISTA antibody. **** NK-Cell and APC/Myeloid-Cell Protein Panels contain the same CD11b and CD16 antibody.
Product Notices: This reagent is provided lyophilized in a pre-titrated format. The production process underwent stringent testing and validation to assure that it generates a high-quality conjugate with consistent performance and specific binding activity. However, verification testing has not been performed on all conjugate lots. Go to https://www.bdbiosciences.com/en-us/resources/protocols/single-cell-multiomics for technical protocols. Go to https://abseq-ref-gen.genomics.bd.com/to access AbSeq reference files in FASTA format for bioinformatics analyses. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing. Follow state and local guidelines when disposing of hazardous waste. Source of all serum proteins is from USDA inspected abattoirs located in the United States. For U.S. patents that may apply, see bd.com/patents. Read and understand the safety data sheets (SDSs) before handling chemicals.To obtain SDSs, go to regdocs.bd.com or contact BD Biosciences technical support at scomix@bd.com.
Tables: Description: Quantity/Size: Quantity/Size Part Number: Part Number EntrezGene ID: EntrezGene ID
Description: Quantity/Size: 1.0 Part Number: N/A EntrezGene ID: N/A